Original Research
Accepted on 07 Apr 2025
In vitro study: HIF-1α-dependent Glycolysis Enhances NETosis in Hypoxic Conditions
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1583587
Type at least 3 characters
7,540 articles
Original Research
Accepted on 07 Apr 2025
Safety and necessity of omitting mediastinal lymph node dissection in cN0/N1 non-small cell lung cancer after neoadjuvant immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1587658
Case Report
Accepted on 07 Apr 2025
Subacute Cutaneous Lupus Erythematosus Triggered by Sintilimab: A Case Report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1544312
Correction
Accepted on 07 Apr 2025
Corrigendum: Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1606194
Review
Accepted on 07 Apr 2025
ICI-induced Cardiovascular Toxicity: Mechanisms and Immune Reprogramming Therapeutic Strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1550400
Original Research
Accepted on 07 Apr 2025
Development and validation of an ARID1A-related immune genes risk model in evaluating prognosis and immune therapeutic efficacy for gastric cancer patients: a translational study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1541491
Review
Accepted on 07 Apr 2025
An Update on the Clinical Trial Research of Immunotherapy for Glioblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1582296
- 150 views
Review
Accepted on 07 Apr 2025
Engaging T cells for cleanup
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1551424
- 127 views
Original Research
Accepted on 07 Apr 2025
Integrative single-cell RNA sequencing and bulk RNA sequencing reveals the characteristics of glutathione metabolism and protective role of GSTA4 gene in pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571431
Original Research
Accepted on 07 Apr 2025
Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571285
Original Research
Accepted on 07 Apr 2025
RBM15-mediated Metabolic Reprogramming Boosts Immune Response in Colorectal Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1515568
Original Research
Accepted on 07 Apr 2025
Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1575181
Review
Accepted on 07 Apr 2025
The molecular mechanisms, roles, and potential applications of PANoptosis in cancer treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1550800
Case Report
Accepted on 07 Apr 2025
Use of sintilimab in primary adenosquamous carcinoma of the liver results in pathological complete response: A case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1578368
Systematic Review
Accepted on 07 Apr 2025
The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1540751
Original Research
Published on 07 Apr 2025
Abnormally high expression of CHI3L1 in peripheral blood mononuclear cells and serum and their potential diagnosis and prediction from lymphoma patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557802
- 343 views